Kirby A M Brennan1, Ann-Marie Creaven2,3. 1. Department of Psychology, University of Limerick, Limerick, Ireland. 2. Department of Psychology, University of Limerick, Limerick, Ireland. Ann-Marie.Creaven@ul.ie. 3. Centre for Social Issues Research, University of Limerick, Limerick, Ireland. Ann-Marie.Creaven@ul.ie.
Abstract
PURPOSE: Because symptoms are not immediately visible to others, systemic lupus erythematosus (SLE) is often considered an invisible illness. This invisibility can reduce the social support received from network members and adversely affect the quality of life. In the light of this, social support from formal support groups and from medical professionals can be particularly important; however, literature examining support from these sources is scarce. The purpose of this study was to explore the nature and impact of social support from medical professionals and from support groups for individuals with SLE. METHODS: Participants responded to open-ended questions on an online survey administered by Lupus UK and Lupus Group Ireland. Qualitative data from 133 participants (77% of respondents) were analysed. RESULTS: Thematic analysis revealed three overarching themes: invisibility, inadequate care, and validation. Respondents felt that their SLE was invisible to social ties and to medical professionals. In addition, treatment and organisational factors in health care contributed to the sense of inadequate care. Finally, validation was derived from informational and emotional support from both support groups, and from some medical professionals. CONCLUSIONS: The findings suggest that individuals with SLE have mixed experiences in terms of contact with medical professionals and involvement with support groups. Furthermore, low public awareness of lupus appears to contribute to feelings of invisibility for patients, leading to loneliness and isolation. Medical professionals might benefit from skills training in terms of managing the psychosocial consequences of lupus.
PURPOSE: Because symptoms are not immediately visible to others, systemic lupus erythematosus (SLE) is often considered an invisible illness. This invisibility can reduce the social support received from network members and adversely affect the quality of life. In the light of this, social support from formal support groups and from medical professionals can be particularly important; however, literature examining support from these sources is scarce. The purpose of this study was to explore the nature and impact of social support from medical professionals and from support groups for individuals with SLE. METHODS:Participants responded to open-ended questions on an online survey administered by Lupus UK and Lupus Group Ireland. Qualitative data from 133 participants (77% of respondents) were analysed. RESULTS: Thematic analysis revealed three overarching themes: invisibility, inadequate care, and validation. Respondents felt that their SLE was invisible to social ties and to medical professionals. In addition, treatment and organisational factors in health care contributed to the sense of inadequate care. Finally, validation was derived from informational and emotional support from both support groups, and from some medical professionals. CONCLUSIONS: The findings suggest that individuals with SLE have mixed experiences in terms of contact with medical professionals and involvement with support groups. Furthermore, low public awareness of lupus appears to contribute to feelings of invisibility for patients, leading to loneliness and isolation. Medical professionals might benefit from skills training in terms of managing the psychosocial consequences of lupus.
Entities:
Keywords:
Illness; Lupus; Qualitative; Quality of life; Social support; Thematic analysis
Authors: Emily C Somers; Wendy Marder; Patricia Cagnoli; Emily E Lewis; Peter DeGuire; Caroline Gordon; Charles G Helmick; Lu Wang; Jeffrey J Wing; J Patricia Dhar; James Leisen; Diane Shaltis; W Joseph McCune Journal: Arthritis Rheumatol Date: 2014-02 Impact factor: 10.995
Authors: Melanie Sloan; Felix Naughton; Rupert Harwood; Elliott Lever; David D'Cruz; Stephen Sutton; Chanpreet Walia; Paul Howard; Caroline Gordon Journal: Rheumatol Adv Pract Date: 2020-07-22
Authors: Melanie Sloan; Michael Bosley; Moira Blane; Lynn Holloway; Colette Barrere; David D'Cruz; Chanpreet Walia; Felix Naughton; Paul Howard; Stephen Sutton; Caroline Gordon Journal: Rheumatol Int Date: 2020-10-26 Impact factor: 2.631